Header Logo

Connection

DAVID GRAHAM to Clarithromycin

Back to Details
This is a "connection" page, showing publications DAVID GRAHAM has written about Clarithromycin.
DAVID GRAHAM
Connection Strength
8.408
Clarithromycin
  1. Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance. J Gastroenterol Hepatol. 2021 May; 36(5):1159-1163.
    View in: PubMed
    Score: 0.646
  2. Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance. Dig Dis Sci. 2016 11; 61(11):3215-3220.
    View in: PubMed
    Score: 0.490
  3. Letter: clarithromycin dose for H.?pylori therapy remains unresolved. Aliment Pharmacol Ther. 2015 Sep; 42(5):631-2.
    View in: PubMed
    Score: 0.455
  4. Treatment of Helicobacter pylori in Latin America. Lancet. 2012 Feb 04; 379(9814):408; author reply 408-9.
    View in: PubMed
    Score: 0.355
  5. Detection of clarithromycin resistance in Helicobacter pylori following noncryogenic storage of rapid urease tests for 30 days. J Dig Dis. 2012 Jan; 13(1):54-9.
    View in: PubMed
    Score: 0.353
  6. Understanding and appreciating sequential therapy for Helicobacter pylori eradication. J Clin Gastroenterol. 2011 Apr; 45(4):309-13.
    View in: PubMed
    Score: 0.335
  7. Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days. Helicobacter. 2011 Apr; 16(2):139-45.
    View in: PubMed
    Score: 0.335
  8. Why the Vonoprazan Helicobacter pylori Therapies in the US-European Trial Produced Unacceptable Cure Rates. Dig Dis Sci. 2023 05; 68(5):1691-1697.
    View in: PubMed
    Score: 0.191
  9. Response to: a true point-of-care molecular testing method for tailored therapy for Helicobacter pylori eradication. Expert Rev Gastroenterol Hepatol. 2023 03; 17(3):311.
    View in: PubMed
    Score: 0.191
  10. How widespread and convenient H. pylori susceptibility testing will result in pharmacological opportunities. Expert Rev Gastroenterol Hepatol. 2023 Jan; 17(1):1-7.
    View in: PubMed
    Score: 0.189
  11. Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why. Am J Gastroenterol. 2022 04 01; 117(4):524-528.
    View in: PubMed
    Score: 0.180
  12. Comparable Results of Helicobacter pylori Antibiotic Resistance Testing of Stools vs Gastric Biopsies Using Next-Generation Sequencing. Gastroenterology. 2022 06; 162(7):2095-2097.e2.
    View in: PubMed
    Score: 0.178
  13. Diagnosis and Treatment of Helicobacter pylori Infection. Annu Rev Med. 2022 01 27; 73:183-195.
    View in: PubMed
    Score: 0.177
  14. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med. 2001 May 14; 161(9):1217-20.
    View in: PubMed
    Score: 0.169
  15. Molecular-based Helicobacter pylori Susceptibility Testing Is Almost Ready for Prime Time. Gastroenterology. 2021 05; 160(6):1936-1937.
    View in: PubMed
    Score: 0.167
  16. Recent Developments Pertaining to H. pylori Infection. Am J Gastroenterol. 2021 01 01; 116(1):1-3.
    View in: PubMed
    Score: 0.165
  17. Clarithromycin for Helicobacter pylori infection. Expert Opin Pharmacother. 2000 Mar; 1(3):507-14.
    View in: PubMed
    Score: 0.155
  18. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci. 2000 Jan; 45(1):68-76.
    View in: PubMed
    Score: 0.154
  19. Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States. Int J Antimicrob Agents. 1999 Aug; 12(4):341-7.
    View in: PubMed
    Score: 0.149
  20. Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection. Aliment Pharmacol Ther. 1999 Feb; 13(2):169-72.
    View in: PubMed
    Score: 0.144
  21. Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals. Gastroenterology. 2018 07; 155(1):67-75.
    View in: PubMed
    Score: 0.136
  22. One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea. Dig Dis Sci. 1998 Mar; 43(3):464-7.
    View in: PubMed
    Score: 0.135
  23. Helicobacter pylori management in ASEAN: The Bangkok consensus report. J Gastroenterol Hepatol. 2018 Jan; 33(1):37-56.
    View in: PubMed
    Score: 0.134
  24. Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother. 1997 Aug; 40(2):283-6.
    View in: PubMed
    Score: 0.130
  25. One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1996 Aug; 10(4):617-21.
    View in: PubMed
    Score: 0.121
  26. Helicobacter pylori therapy: a paradigm shift. Expert Rev Anti Infect Ther. 2016 06; 14(6):577-85.
    View in: PubMed
    Score: 0.119
  27. Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diagn Microbiol Infect Dis. 1996 Jan; 24(1):37-41.
    View in: PubMed
    Score: 0.116
  28. Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy. Gut. 2015 Nov; 64(11):1715-20.
    View in: PubMed
    Score: 0.114
  29. Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther. 1995 Apr; 9(2):209-12.
    View in: PubMed
    Score: 0.111
  30. Improved allele-specific PCR assays for detection of clarithromycin and fluoroquinolone resistant of Helicobacter pylori in gastric biopsies: identification of N87I mutation in GyrA. Diagn Microbiol Infect Dis. 2015 Apr; 81(4):251-5.
    View in: PubMed
    Score: 0.108
  31. Clarithromycin-amoxycillin therapy for Helicobacter pylori infection. Aliment Pharmacol Ther. 1994 Aug; 8(4):453-6.
    View in: PubMed
    Score: 0.106
  32. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. Am J Gastroenterol. 1994 Aug; 89(8):1203-5.
    View in: PubMed
    Score: 0.106
  33. Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests. World J Gastroenterol. 2014 Mar 28; 20(12):3343-9.
    View in: PubMed
    Score: 0.103
  34. Evidence-based recommendations for successful Helicobacter pylori treatment. Expert Rev Gastroenterol Hepatol. 2014 Jan; 8(1):21-8.
    View in: PubMed
    Score: 0.101
  35. Phenotypic and genotypic analysis of clarithromycin-resistant Helicobacter pylori from Bogot? D.C., Colombia. J Microbiol. 2013 Aug; 51(4):448-52.
    View in: PubMed
    Score: 0.099
  36. Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin Gastroenterol Hepatol. 2014 Feb; 12(2):177-86.e3; Discussion e12-3.
    View in: PubMed
    Score: 0.098
  37. Clarithromycin for the eradication of Helicobacter pylori. J Clin Gastroenterol. 1993 Jun; 16(4):292-4.
    View in: PubMed
    Score: 0.097
  38. Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days? Helicobacter. 2011 Apr; 16(2):146-52.
    View in: PubMed
    Score: 0.084
  39. Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol. 2011 Feb; 8(2):79-88.
    View in: PubMed
    Score: 0.083
  40. Helicobacter pylori infection. N Engl J Med. 2010 08 05; 363(6):595-6; author reply 596.
    View in: PubMed
    Score: 0.080
  41. Clinical practice: diagnosis and evaluation of dyspepsia. J Clin Gastroenterol. 2010 Mar; 44(3):167-72.
    View in: PubMed
    Score: 0.078
  42. Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. Clin Gastroenterol Hepatol. 2010 Jan; 8(1):36-41.e1.
    View in: PubMed
    Score: 0.076
  43. Efficient identification and evaluation of effective Helicobacter pylori therapies. Clin Gastroenterol Hepatol. 2009 Feb; 7(2):145-8.
    View in: PubMed
    Score: 0.071
  44. Is there a role for sequential in sequential anti-H. pylori therapy? Gastroenterology. 2006 May; 130(6):1930-1; author reply 1931.
    View in: PubMed
    Score: 0.060
  45. Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border. Aliment Pharmacol Ther. 2006 Jan 15; 23(2):295-301.
    View in: PubMed
    Score: 0.058
  46. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. Helicobacter. 2003 Dec; 8(6):626-42.
    View in: PubMed
    Score: 0.050
  47. Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial). PLoS One. 2023; 18(11):e0294403.
    View in: PubMed
    Score: 0.050
  48. Pilot studies of vonoprazan-containing Helicobacter pylori eradication therapy suggest Thailand may be more similar to the US than Japan. Helicobacter. 2023 Dec; 28(6):e13019.
    View in: PubMed
    Score: 0.050
  49. Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study. Front Immunol. 2022; 13:1049908.
    View in: PubMed
    Score: 0.047
  50. Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe. Am J Gastroenterol. 2023 02 01; 118(2):269-275.
    View in: PubMed
    Score: 0.046
  51. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother. 2001 Apr; 47(4):459-61.
    View in: PubMed
    Score: 0.042
  52. Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother. 2000 Aug; 44(8):2214-6.
    View in: PubMed
    Score: 0.040
  53. Furazolidone combination therapies for Helicobacter pylori infection in the United States. Aliment Pharmacol Ther. 2000 Feb; 14(2):211-5.
    View in: PubMed
    Score: 0.039
  54. Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies. Helicobacter. 1999 Jun; 4(2):106-12.
    View in: PubMed
    Score: 0.037
  55. Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment. Aliment Pharmacol Ther. 2019 06; 49(11):1385-1394.
    View in: PubMed
    Score: 0.037
  56. Optimizing first line 7-day standard triple therapy for Helicobacter pylori eradication: Prolonging treatment or adding bismuth: which is better? J Dig Dis. 2018 Nov; 19(11):674-677.
    View in: PubMed
    Score: 0.035
  57. Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea. Aliment Pharmacol Ther. 1997 Oct; 11(5):939-42.
    View in: PubMed
    Score: 0.033
  58. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017 01; 66(1):6-30.
    View in: PubMed
    Score: 0.031
  59. Resolution of a metaplastic duodenal polyp after cure of Helicobacter pylori infection. J Clin Gastroenterol. 1996 Jul; 23(1):53-4.
    View in: PubMed
    Score: 0.030
  60. Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy). Aliment Pharmacol Ther. 1996 Feb; 10(1):119-22.
    View in: PubMed
    Score: 0.029
  61. Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate. Helicobacter. 2014 Jun; 19(3):207-13.
    View in: PubMed
    Score: 0.026
  62. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol. 1993 Nov; 88(11):1860-4.
    View in: PubMed
    Score: 0.025
  63. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012 May; 61(5):646-64.
    View in: PubMed
    Score: 0.023
  64. Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication. Helicobacter. 2009 Apr; 14(2):109-18.
    View in: PubMed
    Score: 0.018
  65. Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. Clin Infect Dis. 1998 Jul; 27(1):84-9.
    View in: PubMed
    Score: 0.009
  66. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. Helicobacter. 1996 Dec; 1(4):243-50.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.